| Product Code: ETC9949340 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 United Kingdom (UK) Multiplex Testing Market Overview |
3.1 United Kingdom (UK) Country Macro Economic Indicators |
3.2 United Kingdom (UK) Multiplex Testing Market Revenues & Volume, 2021 & 2031F |
3.3 United Kingdom (UK) Multiplex Testing Market - Industry Life Cycle |
3.4 United Kingdom (UK) Multiplex Testing Market - Porter's Five Forces |
3.5 United Kingdom (UK) Multiplex Testing Market Revenues & Volume Share, By Product, 2021 & 2031F |
3.6 United Kingdom (UK) Multiplex Testing Market Revenues & Volume Share, By Technology, 2021 & 2031F |
3.7 United Kingdom (UK) Multiplex Testing Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.8 United Kingdom (UK) Multiplex Testing Market Revenues & Volume Share, By End user, 2021 & 2031F |
4 United Kingdom (UK) Multiplex Testing Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing demand for personalized medicine and precision diagnostics |
4.2.2 Rising prevalence of chronic diseases requiring accurate and timely testing |
4.2.3 Technological advancements in multiplex testing leading to improved efficiency and accuracy |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements and approval processes for multiplex testing products |
4.3.2 High initial investment and operating costs associated with implementing multiplex testing solutions |
4.3.3 Limited awareness and adoption of multiplex testing among healthcare providers and patients |
5 United Kingdom (UK) Multiplex Testing Market Trends |
6 United Kingdom (UK) Multiplex Testing Market, By Types |
6.1 United Kingdom (UK) Multiplex Testing Market, By Product |
6.1.1 Overview and Analysis |
6.1.2 United Kingdom (UK) Multiplex Testing Market Revenues & Volume, By Product, 2021- 2031F |
6.1.3 United Kingdom (UK) Multiplex Testing Market Revenues & Volume, By Reagents, 2021- 2031F |
6.1.4 United Kingdom (UK) Multiplex Testing Market Revenues & Volume, By Consumables, 2021- 2031F |
6.1.5 United Kingdom (UK) Multiplex Testing Market Revenues & Volume, By Others, 2021- 2031F |
6.2 United Kingdom (UK) Multiplex Testing Market, By Technology |
6.2.1 Overview and Analysis |
6.2.2 United Kingdom (UK) Multiplex Testing Market Revenues & Volume, By xMAP (Multi-Analyte Profiling), 2021- 2031F |
6.2.3 United Kingdom (UK) Multiplex Testing Market Revenues & Volume, By RT-PCR (Real Time Polymerase Chain Reaction), 2021- 2031F |
6.2.4 United Kingdom (UK) Multiplex Testing Market Revenues & Volume, By ELISA (Enzyme-Linked Immunosorbent Assay), 2021- 2031F |
6.2.5 United Kingdom (UK) Multiplex Testing Market Revenues & Volume, By Others, 2021- 2031F |
6.3 United Kingdom (UK) Multiplex Testing Market, By Application |
6.3.1 Overview and Analysis |
6.3.2 United Kingdom (UK) Multiplex Testing Market Revenues & Volume, By Influenza A, 2021- 2031F |
6.3.3 United Kingdom (UK) Multiplex Testing Market Revenues & Volume, By Influenza B, 2021- 2031F |
6.3.4 United Kingdom (UK) Multiplex Testing Market Revenues & Volume, By Parainfluenza Viruses, 2021- 2031F |
6.3.5 United Kingdom (UK) Multiplex Testing Market Revenues & Volume, By Adenovirus, 2021- 2031F |
6.3.6 United Kingdom (UK) Multiplex Testing Market Revenues & Volume, By Respiratory Syncytial Virus (RSV), 2021- 2031F |
6.3.7 United Kingdom (UK) Multiplex Testing Market Revenues & Volume, By Coronaviruses, 2021- 2031F |
6.3.8 United Kingdom (UK) Multiplex Testing Market Revenues & Volume, By Group Rhino- and Enteroviruses, 2021- 2031F |
6.3.9 United Kingdom (UK) Multiplex Testing Market Revenues & Volume, By Group Rhino- and Enteroviruses, 2021- 2031F |
6.4 United Kingdom (UK) Multiplex Testing Market, By End user |
6.4.1 Overview and Analysis |
6.4.2 United Kingdom (UK) Multiplex Testing Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.4.3 United Kingdom (UK) Multiplex Testing Market Revenues & Volume, By Clinical Laboratories, 2021- 2031F |
6.4.4 United Kingdom (UK) Multiplex Testing Market Revenues & Volume, By Pharmaceutical and Biotechnology Companies, 2021- 2031F |
6.4.5 United Kingdom (UK) Multiplex Testing Market Revenues & Volume, By Research Institutes, 2021- 2031F |
6.4.6 United Kingdom (UK) Multiplex Testing Market Revenues & Volume, By Others, 2021- 2031F |
7 United Kingdom (UK) Multiplex Testing Market Import-Export Trade Statistics |
7.1 United Kingdom (UK) Multiplex Testing Market Export to Major Countries |
7.2 United Kingdom (UK) Multiplex Testing Market Imports from Major Countries |
8 United Kingdom (UK) Multiplex Testing Market Key Performance Indicators |
8.1 Average turnaround time for test results |
8.2 Number of multiplex testing panels offered by key market players |
8.3 Rate of adoption of multiplex testing in different healthcare settings |
8.4 Number of collaborations and partnerships between testing laboratories and healthcare institutions |
8.5 Percentage of revenue invested in research and development for improving multiplex testing technologies |
9 United Kingdom (UK) Multiplex Testing Market - Opportunity Assessment |
9.1 United Kingdom (UK) Multiplex Testing Market Opportunity Assessment, By Product, 2021 & 2031F |
9.2 United Kingdom (UK) Multiplex Testing Market Opportunity Assessment, By Technology, 2021 & 2031F |
9.3 United Kingdom (UK) Multiplex Testing Market Opportunity Assessment, By Application, 2021 & 2031F |
9.4 United Kingdom (UK) Multiplex Testing Market Opportunity Assessment, By End user, 2021 & 2031F |
10 United Kingdom (UK) Multiplex Testing Market - Competitive Landscape |
10.1 United Kingdom (UK) Multiplex Testing Market Revenue Share, By Companies, 2024 |
10.2 United Kingdom (UK) Multiplex Testing Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here